Literature DB >> 28490001

Zika Virus Vaccines - A Full Field and Looking for the Closers.

Stephen J Thomas1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28490001     DOI： 10.1056/NEJMcibr1701402

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  4 in total

1.  Zika vaccine pre-clinical and clinical data review with perspectives on the future development.

Authors:  Stephen J Thomas; Alan Barrett
Journal:  Hum Vaccin Immunother       Date:  2020-07-23       Impact factor: 3.452

2.  Differential human antibody repertoires following Zika infection and the implications for serodiagnostics and disease outcome.

Authors:  Supriya Ravichandran; Megan Hahn; Pablo F Belaunzarán-Zamudio; José Ramos-Castañeda; Gabriel Nájera-Cancino; Sandra Caballero-Sosa; Karla R Navarro-Fuentes; Guillermo Ruiz-Palacios; Hana Golding; John H Beigel; Surender Khurana
Journal:  Nat Commun       Date:  2019-04-26       Impact factor: 14.919

3.  Neutralization of Zika virus by germline-like human monoclonal antibodies targeting cryptic epitopes on envelope domain III.

Authors:  Yanling Wu; Shun Li; Lanying Du; Chunyu Wang; Peng Zou; Binbin Hong; Mengjiao Yuan; Xiaonan Ren; Wanbo Tai; Yu Kong; Chen Zhou; Lu Lu; Xiaohui Zhou; Shibo Jiang; Tianlei Ying
Journal:  Emerg Microbes Infect       Date:  2017-10-11       Impact factor: 7.163

4.  Chimeric yellow fever 17D-Zika virus (ChimeriVax-Zika) as a live-attenuated Zika virus vaccine.

Authors:  Maryann Giel-Moloney; Ana P Goncalvez; John Catalan; Valerie Lecouturier; Yves Girerd-Chambaz; Fernando Diaz; Francisco Maldonado-Arocho; Raul C Gomila; Marie-Clotilde Bernard; Ray Oomen; Simon Delagrave; Nicolas Burdin; Harold Kleanthous; Nicolas Jackson; Jon Heinrichs; Konstantin V Pugachev
Journal:  Sci Rep       Date:  2018-09-04       Impact factor: 4.379
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.